Countdown to #AUA24 ; looking forward to the
AUA-IBCG Bladder Cancer Forum
Sunday, May 5, 2 - 5 pm

Amer. Urol. Assn. IBCG Janet Kukreja Amanda Myers Bladder Cancer Advocacy Network Andrea Necchi Petros Grivas Roger Li Karima Oualla, MD,MSc Shilpa Gupta Stephen B. Williams, MD, MBA, MS, FACHE Prof Param Mariappan

Meeting of the Young Academics of the EAU European Association of Urology (EAU) at #EAU24
Publications in 2023: 126
Members: 194
Participations at EAU Congress: 89
EAU abstract reviewers: 56
Awards: 5
Countless collaborations with our best friend European Association of Urology (EAU)ESU
Motivation and illusion: infinite 🚀

IBCG intermediate-risk #NMIBC scoring system predicts the need for intervention for patients on active surveillance. Presented by Roberto Contieri
Humanitas Milano. #EAU24 written coverage by Rashid K. Sayyid University of Toronto > bit.ly/3xlPo7U European Association of Urology (EAU)

Kudos to Amanda Myers for winning best abstract at this session #EAU24 !

Let's challenge our own beliefs to better inform patients on their options

MD Anderson Cancer Center #OncSurgery Wei Shen Tan Valentina Grajales MD, MS Kelly Bree Neema Navai IBCG World Bladder Cancer Patient Coalition Bladder Cancer Advocacy Network

Dr Contieri Roberto Contieri presenting our collaborative work at #EAU24 showing that IBCG IR NMIBC system predicts delayed TURBT in patients under active surveillance

empowering informed decision-making and enhanced patient counseling

MD Anderson Cancer Center #OncSurgery

Once again Humanitas University proved to be the protagonist during the EAU Congress (European Urology Congress, Paris ‘24). I thank all the residents for their contribution to this event.

Defining follow-up strategies for patients with primary European Association of Urology (EAU) 2021 intermediate-risk non-muscle invasive #BladderCancer . Presentation by Roberto Contieri Humanitas Milano. #EAU24 written coverage by Zach Klaassen Georgia Cancer Center > bit.ly/3TFVVC0

Excited to have joined my first YAU brainstorm meeting at #EAU24 ! Eager to kickstart work with this amazing group!

Our team #EAU24

👏👏👏 David D'Andrea for Winning the European Association of Urology (EAU) Hans Marberger🏆 with a multicentric RCT on #ERBT vs standard #TURBT

EAU Young Urologists Juan Gómez Rivas Marco Moschini Francesco Del Giudice Ekaterina Laukhtina Benjamin Pradere francesco soria Gautier Marcq Luca Afferi Jose Daniel Subiela Roberto Contieri

Thrilling debate on micropapillary NMIBC treatment in a fully-packed room for the rapid-fire debate on BC: upfront radical cystectomy (Ashish M. Kamat, MD, MBBS) vs. intravesical therapy (@BenjaminPradere) #EAU24

#EAU24 Ashish M. Kamat, MD, MBBS opening one of the most awaited session in Bladder Cancer!
Let's start the Rapid-fire debates!

Can't miss #EAU24 #RapidFireDebate How do we manage a patient with frequent recurrence of LG papillary tumors in the bladder despite intravesical chemotherapy and BCG therapy? Marek Babjuk Kenneth Philippe spiess Ashish M. Kamat, MD, MBBS

Succinct commentary by Dr. Bishoy M. Faltas on our work on age disparity in NMIBC with SEER/UROMOL data

♦️⬆️ age a/w ⬇️ outcomes

♦️Tumour biology differs across transcriptomic & genomic domains

Niyati Lobo Akshay Sood Wei Shen Tan Sia Viborg Lindskrog Stephen B. Williams, MD, MBA, MS, FACHE Roberto Contieri Kelly Bree Lars Dyrskjøt

Check out #bladdercancer podium/posters by
MD Anderson Cancer Center Society of Urologic Oncology fellows & rotating residents #KamatLab #EAU24 #EAU2024 #OncSurgery

Collaborations: IBCG Omar Alhalabi, MD Humanitas Milano

Roberto Contieri Amanda Myers
Alberto Martini Valentina Grajales MD, MS Wei Shen Tan

Influence of lamina propria invasion extension on T1 high-grade non-muscle-invasive bladder cancer in patients undergoing BCG or radical cystectomy
Roberto Contieri Alberto Martini Valentina Grajales MD, MS Wei Shen Tan Kelly Bree MD Anderson Cancer Center Ashish M. Kamat, MD, MBBS

doi.org/10.1111/bju.16…

Enfortumab + Pembro outperforms platinum chemotherapy in advanced UC with a doubling of PFS and a halving of the risk of death @nejm. G3/4 AEs of 56% for EVP vs 70% for chemo & CR=29%. Editorial by @gniegisch ‘EVP is the new standard against which future trials must be compared’

Join us April 5th for the 7th edition of
Rapid Fire Debates in #BladderCancer
#EAU2024 #EAU24
Morgan Roupret Sarah P. Psutka MD MS Andrea Necchi Joan Palou Redorta evacomperat Philippe spiess Benjamin Pradere Jørgen Bjerggaard 💙alison birtle Marek Babjuk Paolo Gontero jim catto Peter Black Arnulf Stenzl European Association of Urology (EAU)

Great to immerse in two days of learning at the EAU Masterclass on NMIBC in Prague, guided by an extraordinary faculty of experts. European Association of Urology (EAU)

Let's meet during the ESU-ESOU Masterclass on Non-muscle-invasive bladder cancer, which will take place on February 29 & and March 1, 2024, in Prague, Czech Republic. As always, the latest updates on Bladder EpiCheck®; What else..
Camille Berquin Roberto Contieri European Association of Urology (EAU)